Calidad de vida en pacientes con esclerosis múltiple atendidos en una institución de salud de Medellín, Colombia
DOI:
https://doi.org/10.22267/rus.192103.159Palabras clave:
Esclerosis múltiple, Calidad de vida relacionada con la salud, Personas con discapacidad, Actividades de la vida diaria, Factores de riesgoResumen
Introducción: La calidad de vida relacionada con salud (CVRS) en la esclerosis múltiple (EM), puede verse afectada por factores físicos, clínicos y sociodemográficos. Objetivo: Determinar el efecto de factores sociodemográficos, clínicos y físicos en la calidad de vida (CV) de pacientes con EM. Métodos: Se aplicó el instrumento WHOQOL-BREF de la OMS a 173 pacientes de una institución de salud. Se realizó análisis descriptivo de características sociodemográficas, clínicas y físicas y sus puntajes de CV. Se observó la asociación entre CV global con factores sociodemográficos, clínicos y físicos; finalmente, por medio de análisis multivariado. Resultados: El 80,3% fueron mujeres, la mediana de edad de 43 años (RIC= 51-35). La fatiga fue el síntoma más frecuente ((71%). Los factores de riesgo para tener peor CV fueron: sexo femenino (RP=6,92. IC 95% 1,8-26,58), alteración en control de esfínteres (RP= 6,10 IC 95% 1,26-29,51), trastornos cognitivos (RP=4,46 IC 95% 1,07-18,56), riesgo de depresión (RP= 3,82 IC 95% 1,01-14,38) y no realizar fisioterapia (RP= 4,48 IC 95% 1,08-18,34). Conclusiones: La afectación de CV en la EM, según factores sociodemográficos y clínicos es variable. Evaluar la CVRS en la práctica clínica, permite entender el comportamiento y necesidades del paciente para intervenir factores de riesgo.
Descargas
Métricas
Citas
Kidd T, Carey N, Mold F. A systematic review of the effectiveness of self-management interventions in people with multiple sclerosis at improving depression, anxiety and quality of life. PLoS One. 2017;12(10):e0185931.
Browne P, Chandraratna D, Angood C. Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity. Neurology. 2014;83(11):1022–4.
Montalban X, Gold R, Thompson AJ. ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis. Mult Scler J. 2018;24(2):96–120.
Hart FM, Bainbridge J. Current and emerging treatment of multiple sclerosis. Am J Manag Care. 2016;22(6):159–70.
Vargas DL, Tyor WR. Update on disease-modifying therapies for multiple sclerosis. J Investig Med. 2017;65(5):883–91.
Vargas DL, Tyor WR. Update on disease-modifying therapies for multiple sclerosis. J Investig Med. 2017;65(5):883–91.
Fernández O, Baumstarck-Barrau, Karine S. Patient characteristics and determinants of quality of life in an international population with multiple sclerosis: Assessment using the MusiQoL and SF-36 questionnaires. Mult Scler J. 2011;17(10):1238–49.
Baumstarck K, Pelletier J, Butzkueven H. Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis. Eur J Neurol. 2013;20(6):907–14.
Ivanova JI, Birnbaum HG, Samuels S, Davis M, Phillips AL, Meletiche D. The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US. Pharmacoeconomics. 2009;27(8):681-91.
Cores E V, Vanotti S, Burin DI. Factores asociados con la situación laboral de pacientes con esclerosis múltiple TT - Factors associated to the work situation of patients with multiple sclerosis. Rev Neurol. 2014;58(4):175–83.
Patti F. Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis. Mult Scler. 2007;13(6):783–91.
Benedict RH, Wahlig E, Bakshi R, Fishman I, Munschauer F, Zivadinov R, et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci. 2005;231(1–2):29–34.
Olascoaga J. Calidad de vida y esclerosis múltiple. Rev Neurol. 2010;51(5):279–88.
Simeoni MC, Auquier P, Fernandez O et al. Validation of the Multiple Sclerosis International. Mult Scler. 2008;14(April 2007):219–30.
Fernández O, Fernández V, Baumstarck-Barrau. Validation of the spanish version of the multiple sclerosis international quality of life (musiqol) questionnaire. BMC Neurol. 2011;11(1):127.
Boucher F, Baumstarck K, Acquadro C. Challenges In Translating The Multiple Sclerosis International Quality of Life (Musiqol) Questionnaire In 57 Languages. Value Heal. 2015;18(7):A762.
Gracia F, Larreategui M, Rodríguez G. Costs of multiple sclerosis in Panama from societal, patient perspectives and healthrelated quality of life. PLoS One. 2018;13(10):1–12.
WHOQOL. Development of the WHOQOL: Rationale and Current Status. Int J Ment Health. 2014;23(3):24–56.
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–1444.
William WK, Zung MD. A self rating depression scale. Arch gen psych. 1965;12:63–70.
William WK. Factors influencing the Self-Rating Depression Scale. Arch Gen Psychiat. 1967;16:543–7.
Campo-Arias A. Comparación de algunas propiedades psicométricas de la escala de Zung para depresión con puntuaciones dicotómicas. Rev Colomb Psiquiatr. 2006;35(4):511–8.
Campo-Arias A, Díaz-Martínez LA, Rueda-Jaimes GE. Validación de la escala de Zung para depresión en universitarias de Bucaramanga, Colombia Validation of Zung’s Self-Rating Depression Scale Among Universitary Student Women from Bucaramanga , Colombia. Rev Colomb Psiquiatr. 2005;34(1):54–62.
Polman CH, Reingold SC. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.
Alan J Thompson, Brenda L Banwell FB. Diagnosis of multiple sclerosis: revision of the McDonald criteria 2017. Lancet Neurol. 2018;89(17):162–73.
Salter AR, Cutter GR, Tyry T. Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS. Curr Med Res Opin. 2010;26(2):493–500.
De DEM. Informe mundial sobre el empleo y la EM 2016. 2016;1–3.
Smith C, Hale L, Olson K. How does exercise influence fatigue in people with multiple sclerosis. Disabil Rehabil. 2009;31(9):685–92.
Freeman JA, Hendrie W, Creanor S. Standing up in multiple sclerosis (SUMS): Protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis. BMC Neurol. 2016;16(1):1–10.
Benito-León J, Mitchell AJ, Rivera-Navarro J. Impaired health-related quality of life predicts progression of disability in multiple sclerosis. Eur J Neurol. 2013;20(1):79–86.
Wilski M, Tasiemski T. Health-related quality of life in multiple sclerosis: role of cognitive appraisals of self, illness and treatment. Qual Life Res. 2016;25(7):1761–70.
Yalachkov Y, Soydaş D, Bergmann J. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis. Mult Scler Relat Disord. 2019;30(January):33–7.
Wang Y, Gorenstein C. Assessment of depression in medical patients: A systematic review of the utility of the Beck Depression Inventory-II. Clinics. 2013;68(9):1274–87.
Tepavčević DK, Pekmezović T, Drulović J. Quality of life assessment in patients with multiple sclerosis | Ispitivanje kvaliteta života bolesnika sa multiplom sklerozom. Vojnosanit Pregl. 2009;66(8):645–51.
Arnett P, Ben-Zacharia A, Benedict R. The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler. 2005;11(3):328–37.
Sánchez-López MP, Olivares-Pérez T, Nieto-Barco A. Esclerosis múltiple y depresión. Rev Neurol. 2004;38(6):524–9.
Hale LA, Smith C, Mulligan H. Tell me what you want, what you really really want..: Asking people with multiple sclerosis about enhancing their participation in physical activity. Disabil Rehabil. 2012;34(22):1887–93.
Tabrizi FM, Radfar M. Fatigue, sleep quality, and disability in relation to quality of life in multiple sclerosis. Int J MS Care. 2015;17(6):268–74.
Virtanen A, Ruutiainen J, Aunola S. Effects of a 6-month exercise program on patients with multiple sclerosis: a randomized study. Neurology. 2004;63(11):2034–8.
Halabchi F, Alizadeh Z, Sahraian MA. Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations. BMC Neurol. 2017;17(1):1–11.
Dalgas U. Exercise therapy in multiple sclerosis and its effects on function and the brain. Neurodegener Dis Manag. 2017;7(6):35–40.
